Direkt zum Inhalt
Merck

Extensive lichenoid drug eruption due to glyburide: a case report and review of the literature.

Cutis (2005-09-08)
Gary N Fox, Colleen C Harrell, Darius R Mehregan
ZUSAMMENFASSUNG

Lichenoid reactions to sulfonylurea drugs have been reported, albeit infrequently. To our knowledge, this is the first case of a generalized lichenoid dermatitis likely induced by the third-generation sulfonylurea hypoglycemic drug glyburide.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Glyburid (Glibenclamid), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glybenclamid, ≥99% (HPLC)
Sigma-Aldrich
Glyburid, meets USP testing specifications
Glibenclamid für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Glybenclamid, European Pharmacopoeia (EP) Reference Standard